Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study

View ORCID ProfileAude Richard, Ania Wisniak, Javier Perez-Saez, Henri Garrison-Desany, Dusan Petrovic, Giovanni Piumatti, Hélène Baysson, Attilio Picazio, Francesco Pennacchio, David De Ridder, François Chappuis, Nicolas Vuilleumier, View ORCID ProfileNicola Low, Samia Hurst, Isabella Eckerle, Antoine Flahault, Laurent Kaiser, Andrew S Azman, Idris Guessous, Silvia Stringhini, For the SEROCOV-POP study group
doi: https://doi.org/10.1101/2020.12.16.20248180
Aude Richard
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
2Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aude Richard
  • For correspondence: aude.richard{at}unige.ch
Ania Wisniak
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
2Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Perez-Saez
2Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henri Garrison-Desany
3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dusan Petrovic
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
4University Centre for General Medicine and Public Health (UNISANTE), University of Lausanne, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Piumatti
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
5Faculty of BioMedicine, Università della Svizzera Italiana, Lugano, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hélène Baysson
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
6Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Attilio Picazio
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Pennacchio
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David De Ridder
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
6Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Chappuis
6Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
7Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Vuilleumier
8Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
9Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Low
10Institute of Social and Preventive Medicine, Faculty of Medicine, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicola Low
Samia Hurst
11Institute for Ethics, History, and the Humanities, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabella Eckerle
12Geneva Center for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland
13Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Flahault
2Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
6Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
7Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Kaiser
9Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
12Geneva Center for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland
14Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew S Azman
2Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Idris Guessous
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
6Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Stringhini
1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
4University Centre for General Medicine and Public Health (UNISANTE), University of Lausanne, Lausanne, Switzerland
6Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Population-based serological surveys provide a means for assessing the immunologic landscape of a community, without the biases related to health-seeking behaviors and testing practices typically associated with rt-PCR testing. This study assesses SARS-CoV-2 seroprevalence over the first epidemic wave in Canton Geneva, Switzerland, as well as biological and socio-economic risk factors for infection and symptoms associated with IgG seropositivity.

Methods and findings Between April 6 and June 30, 2020, former participants of a yearly representative cross-sectional survey of the 20-75-year-old population of the canton of Geneva were invited to participate in a seroprevalence study, along with household members five years and older. We collected blood and tested it for anti-SARS-CoV-2 immunoglobulins G (IgG). Questionnaires were self-administered. We estimated seroprevalence with a Bayesian model accounting for test performance and sampling design. We included 8344 participants (53.5% women, mean age 46.9 years). The population-level seroprevalence over the 12-week study period was 7.8 % (95% Credible Interval (CrI) 6.8-8.9), accounting for sex, age and household random effects. Seroprevalence was highest among 18-49 year olds (9.5%, 95%CrI 8.1-10.9), with young children (5-9 years) and those >65 years having significantly lower seroprevalence (4.3% and 4.7-5.4% respectively). Men were more likely to be seropositive than women (relative risk 1.2, 95%CrI 1.1-1.4). Odds of seropositivity were reduced for female retirees (0.46, 95%CI 0.23-0.93) and unemployed men (0.35, 95%CI 0.13-1.0) compared to employed individuals, and for current smokers (0.36, 95%CI 0.23-0.55) compared to never-smokers. We found no significant association between occupation, level of education, neighborhood income and the risk of being seropositive. Symptoms most strongly associated with seropositivity were anosmia/dysgeusia, loss of appetite, fever, fatigue and myalgia and/or arthralgia. Thirteen percent of seropositive participants reported no symptoms.

Conclusions Our results confirm a low population seroprevalence of anti-SARS-CoV-2 antibodies after the first wave in Geneva, a region hard hit by the COVID-19 pandemic. Socioeconomic factors were not associated with seropositivity in this sample. The elderly and young children were less frequently seropositive, though it is not clear how biology and behaviors shape these differences. These specificities should be considered when assessing the need for targeted public health measures.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Swiss Federal Office of Public Health, the Corona Immunitas research program of the Swiss School of Public Health, the Fondation de Bienfaisance du Groupe Pictet, the Fondation Ancrage, the Fondation Priv&eacutee des HUG, and the Center for Emerging Viral Diseases.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the Cantonal Research Ethics Commission of Geneva, Switzerland (CER16-363).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez-Saez, Henri Garrison-Desany, Dusan Petrovic, Giovanni Piumatti, Hélène Baysson, Attilio Picazio, Francesco Pennacchio, David De Ridder, François Chappuis, Nicolas Vuilleumier, Nicola Low, Samia Hurst, Isabella Eckerle, Antoine Flahault, Laurent Kaiser, Andrew S Azman, Idris Guessous, Silvia Stringhini, For the SEROCOV-POP study group
medRxiv 2020.12.16.20248180; doi: https://doi.org/10.1101/2020.12.16.20248180
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez-Saez, Henri Garrison-Desany, Dusan Petrovic, Giovanni Piumatti, Hélène Baysson, Attilio Picazio, Francesco Pennacchio, David De Ridder, François Chappuis, Nicolas Vuilleumier, Nicola Low, Samia Hurst, Isabella Eckerle, Antoine Flahault, Laurent Kaiser, Andrew S Azman, Idris Guessous, Silvia Stringhini, For the SEROCOV-POP study group
medRxiv 2020.12.16.20248180; doi: https://doi.org/10.1101/2020.12.16.20248180

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (432)
  • Allergy and Immunology (758)
  • Anesthesia (221)
  • Cardiovascular Medicine (3306)
  • Dentistry and Oral Medicine (365)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1174)
  • Epidemiology (13391)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5165)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3280)
  • Health Policy (1144)
  • Health Systems and Quality Improvement (1196)
  • Hematology (432)
  • HIV/AIDS (1021)
  • Infectious Diseases (except HIV/AIDS) (14647)
  • Intensive Care and Critical Care Medicine (914)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4939)
  • Nursing (262)
  • Nutrition (733)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (796)
  • Oncology (2526)
  • Ophthalmology (729)
  • Orthopedics (283)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (545)
  • Pediatrics (1303)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4221)
  • Public and Global Health (7520)
  • Radiology and Imaging (1709)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (499)
  • Sports Medicine (425)
  • Surgery (550)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (206)